A number of trials have been conducted with each of the three main antipneumococcal respiratory fluoroquinolones. In an open-label, noncomparative study, gemifloxacin (320 mg, once daily for 7 ...

A literature search was conducted to evaluate the pharmacokinetic and pharmacodynamic profile of the respiratory fluoroquinolones (gemifloxacin, levofloxacin and moxifloxacin) and their efficacy ...

However, we recently found that the CMY-10 ESBL had higher imipenem-hydrolysing activity than OXA-23 ... C β-lactamases with extended substrate spectrum.

Raman, C. V., Proc. Ind. Acad. Sci., A, 18, 237 (1943).

Free, trusted NHS advice and guidance to help you have a healthy and happy baby during pregnancy, birth and parenthood.